Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 886

1.

Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.

Białecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Jarosz M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Sławek J.

Pharmacogenet Genomics. 2012 Oct;22(10):716-24. doi: 10.1097/FPC.0b013e32835693f7.

PMID:
22890010
2.

Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.

Camicioli RM, Bouchard TP, Somerville MJ.

Mov Disord. 2009 Jan 30;24(2):176-82. doi: 10.1002/mds.22227.

PMID:
18951534
3.

Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson's disease patients.

Yuan RY, Sheu JJ, Yu JM, Hu CJ, Tseng IJ, Ho CS, Yeh CY, Hung YL, Chiang TR.

J Neurol Sci. 2009 Dec 15;287(1-2):64-8. doi: 10.1016/j.jns.2009.09.007. Epub 2009 Sep 27.

PMID:
19786283
4.

Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.

Rodriguez-Oroz MC, Lage PM, Sanchez-Mut J, Lamet I, Pagonabarraga J, Toledo JB, García-Garcia D, Clavero P, Samaranch L, Irurzun C, Matsubara JM, Irigoien J, Bescos E, Kulisevsky J, Pérez-Tur J, Obeso JA.

Mov Disord. 2009 Jul 30;24(10):1437-44. doi: 10.1002/mds.22522.

PMID:
19452554
6.

Common polymorphisms in methylenetetrahydrofolate reductase (MTHFR): relationships with plasma homocysteine concentrations and cognitive status in elderly northern italian subjects.

Ravaglia G, Forti P, Maioli F, Scali RC, Arnone G, Talerico T, Pantieri T, Nativio V, Mantovani V, Bianchin M.

Arch Gerontol Geriatr Suppl. 2004;(9):339-48.

PMID:
15207432
7.

The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.

Sławek J, Roszmann A, Robowski P, Dubaniewicz M, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Gołąb-Janowska M, Koziorowska-Gawron E, Droździk M, Kurzawski M, Bandurski T, Białecka M.

Neurodegener Dis. 2013;12(1):1-12. doi: 10.1159/000338610. Epub 2012 Jul 20.

PMID:
22831964
8.

Association of MTHFR, SLC19A1 Genetic Polymorphism, Serum Folate, Vitamin B12 and Hcy Status with Cognitive Functions in Chinese Adults.

Cai C, Xiao R, Van Halm-Lutterodt N, Zhen J, Huang X, Xu Y, Chen S, Yuan L.

Nutrients. 2016 Oct 24;8(10). pii: E665.

10.

Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD).

de Carvalho SC, Muniz MT, Siqueira MD, Siqueira ER, Gomes AV, Silva KA, Bezerra LC, D'Almeida V, de Oliveira CP, Pereira LM.

Nutr J. 2013 Apr 2;12:37. doi: 10.1186/1475-2891-12-37.

11.

The maternal homocysteine pathway is influenced by riboflavin intake and MTHFR polymorphisms without affecting the risk of orofacial clefts in the offspring.

Vujkovic M, Steegers EA, van Meurs J, Yazdanpanah N, van Rooij IA, Uitterlinden AG, Steegers-Theunissen RP.

Eur J Clin Nutr. 2010 Mar;64(3):266-73. doi: 10.1038/ejcn.2009.138. Epub 2009 Nov 25.

PMID:
19935819
12.

Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.

Nakamura T, Saionji K, Hiejima Y, Hirayama H, Tago K, Takano H, Tajiri M, Hayashi K, Kawabata M, Funamizu M, Makita Y, Hata A.

Am J Kidney Dis. 2002 May;39(5):1032-9.

PMID:
11979347
13.
14.

Endothelial nitric oxide synthase -786T>C, but not 894G>T and 4a4b, polymorphism influences plasma homocysteine concentrations in persons with normal vitamin status.

Fatini C, Sofi F, Gori AM, Sticchi E, Marcucci R, Lenti M, Casini A, Surrenti C, Abbate R, Gensini GF.

Clin Chem. 2005 Jul;51(7):1159-64. Epub 2005 May 19.

16.

Variations in folate pathway genes are associated with unexplained female infertility.

Altmäe S, Stavreus-Evers A, Ruiz JR, Laanpere M, Syvänen T, Yngve A, Salumets A, Nilsson TK.

Fertil Steril. 2010 Jun;94(1):130-7. doi: 10.1016/j.fertnstert.2009.02.025. Epub 2009 Mar 26.

PMID:
19324355
17.

Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.

Arauz A, Hoyos L, Cantú C, Jara A, Martínez L, García I, Fernández Mde L, Alonso E.

Cerebrovasc Dis. 2007;24(2-3):210-4. Epub 2007 Jun 27.

PMID:
17596690
18.

Methionine synthase reductase 66A->G polymorphism is associated with increased plasma homocysteine concentration when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant.

Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, Quinlivan EP, Gregory JF 3rd, Theriaque DW, Kauwell GP.

J Nutr. 2004 Nov;134(11):2985-90.

19.

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients.

Lamberti P, Zoccolella S, Iliceto G, Armenise E, Fraddosio A, de Mari M, Livrea P.

Mov Disord. 2005 Jan;20(1):69-72.

PMID:
15390046
20.

Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms.

Fillon-Emery N, Chango A, Mircher C, Barbé F, Bléhaut H, Herbeth B, Rosenblatt DS, Réthoré MO, Lambert D, Nicolas JP.

Am J Clin Nutr. 2004 Dec;80(6):1551-7.

Supplemental Content

Support Center